Health DiagnosticsNutraceuticalCardiovascularOncologyNeurologyFast-Moving Consumer GoodsHealth CarePharmaceutical
Description
PT Kalbe Farma Tbk., primarily operates in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company focuses on providing high-quality healthcare products and services…
Analysis
Bargain bin
PT Kalbe Farma Tbk. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average. Worth noting: the cash the business generates has lagged behind what the income statement shows.
On valuation, the picture is attractive. The owner-earnings multiple stands at 8.3×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around -6% a year, against analyst forecasts of 11%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 12/20 on our value-creation score: creating some value.
Flags to be aware of: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202395
94
2023202420252026
All-time high
96
May 2023
All-time low
65
Jan 2024
Average rank
88
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
87
73
69
65
Price/Earnings
90
70
58
48
Price/Book
82
66
59
55
Dividend Yield
89
82
71
71
Value (overall)
94
81
75
59
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.